Trends of reported chlamydia infections and related complications in New Zealand, 1998–2008
Jane Morgan A D , Chanukya Colonne B and Anita Bell CA Sexual Health Clinic, Waikato Hospital, Private Bag 3200, Hamilton 3240, New Zealand.
B The University of Sydney, Sydney, NSW 2006, Australia.
C Population Health Service, Waikato District Health Board, PO Box 505, Hamilton 3240, New Zealand.
D Corresponding author. Email: jane.morgan@waikatodhb.health.nz
Sexual Health 8(3) 412-418 https://doi.org/10.1071/SH10101
Submitted: 25 August 2010 Accepted: 20 January 2011 Published: 23 May 2011
Abstract
Aim: To compare trends in chlamydia (Chlamydia trachomatis) testing and detection with trends in hospital discharge rates of chlamydia-related diseases in the upper North Island of New Zealand during 1998–2008. Methods: Analysis of trends in chlamydia testing and detection rates and age-specific hospital admission rates per 100 000 females for pelvic inflammatory disease (PID), female infertility and ectopic pregnancy, and per 100 000 males for epididymo-orchitis. Results: Regional laboratory testing volumes increased from 3732 tests per 100 000 population in 1998 to 9801 tests per 100 000 in 2008. Two of three regions had a significant increase in percent test positivity over time. The highest detection rates and greatest increase in reported cases were amongst women aged 15–24 years, at 1992 per 100 000 in 1998, to 5737 per 100 000 in 2008. For women aged 15–24 years, the rate of hospital admissions for PID and chlamydia-related pelvic infections declined during 1998–2004 but rose in 2005–08, the rate of publicly-funded infertility admissions fell and the ectopic pregnancy rate was unchanged. The age-specific rate for epididymo-orchitis admissions amongst 15–44-year-old men remained stable. Conclusion: Chlamydia testing volumes from three New Zealand regions have trebled since 1998, as have reported infection rates, although disease complication rates do not appear to have increased. Test positivity increases may reflect better targeted testing of those more at risk or a rising chlamydia incidence. The recent rise in hospital admissions for PID among women aged 15–24 is a concern; ongoing monitoring of these trends, despite data limitations, is important.
Additional keywords: ectopic pregnancy, epididymo-orchitis, female infertility, pelvic inflammatory disease.
References
[1] Stamm W. Chlamydia trachomatis infections of the adult. In: Holmes KKSP, Stamm WE, Piot P, Wasserheit JN, Corey L, et al., editors. Sexually transmitted diseases, 4th edn. New York: McGraw-Hill Medical; 2008. pp. 575–93.[2] Gottlieb SL, Brunham RC, Byrne GI, Martin DH, Xu F, Berman SM. Introduction: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control. J Infect Dis 2010; 201 85–7.
| Introduction: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control.Crossref | GoogleScholarGoogle Scholar |
[3] Ministry of Health. 2008 chlamydia management guidelines. Wellington: Ministry of Health; 2008. Available online at: http://www.moh.govt.nz/moh.nsf/pagesmh/8210 [verified February 2011].
[4] STI Surveillance Team. Sexually transmitted infections in New Zealand annual surveillance report 2009. Wellington: Population and Environmental Health Group, Institute of Environmental Science and Research Ltd; 2010. Available online at: www.surv.esr.cri.nz [verified February 2011].
[5] Chen MY, Fairley CK, Donovan B. Discordance between trends in chlamydia notifications and hospital admission rates for chlamydia related diseases in New South Wales, Australia. Sex Transm Infect 2005; 81 318–22.
| Discordance between trends in chlamydia notifications and hospital admission rates for chlamydia related diseases in New South Wales, Australia.Crossref | GoogleScholarGoogle Scholar |
[6] Population Statistics, Statistics New Zealand (January 2010). Available online at: www.stats.govt.nz [verified February 2011].
[7] Egger M, Low N, Davey Smith G, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316 1776–80.
[8] Cassell JA, Low N. How can chlamydia diagnoses increase when their complications are declining? Sex Transm Infect 2005; 81 285–6.
| How can chlamydia diagnoses increase when their complications are declining?Crossref | GoogleScholarGoogle Scholar |
[9] Paavonen J, Westrõm L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KKSP, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, editors. Sexually transmitted diseases, 4th edn. New York: McGraw-Hill; 2008. pp. 1017–50.
[10] Farquhar CM. Ectopic pregnancy. Lancet 2005; 366 583–91.
| Ectopic pregnancy.Crossref | GoogleScholarGoogle Scholar |
[11] Cooray H, Harilall M, Farquhar CM. A six-year audit of the management of ectopic pregnancy. Aust N Z J Obstet Gynaecol 2002; 42 538–42.
| A six-year audit of the management of ectopic pregnancy.Crossref | GoogleScholarGoogle Scholar |
[12] McGee R, Williams S, Stanton W.. Smoking among New Zealand adolescents 1960–93. N Z Med J 1995; 108 85–7.
[13] Ponniah S, Bloomfield A. Sociodemographic characteristics of New Zealand adult smokers, ex-smokers, and non-smokers: results from the 2006 Census. N Z Med J 2008; 121 34–42.
[14] Heuser P, Tonga K, Hopkins R, Henderson M, Weatherall M, Metcalfe S, et al Specific oral contraceptive use and venous thromboembolism resulting in hospital admission. N Z Med J 2004; 117 U1176
[15] Macintosh MC. Trends in ectopic pregnancy in New Zealand. Aust N Z J Obstet Gynaecol 1986; 26 145–8.
| Trends in ectopic pregnancy in New Zealand.Crossref | GoogleScholarGoogle Scholar |
[16] Ministry of Health. Data and Statistics January 2010. Wellington: Ministry of Health; 2010. Available online at: http://www.moh.govt.nz/moh.nsf/indexmh/dataandstatistics-collections [verified February 2011].
[17] Haggerty C, Gottlieb S, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201 134–55.
| Risk of sequelae after Chlamydia trachomatis genital infection in women.Crossref | GoogleScholarGoogle Scholar |
[18] Waetford C, Aspin C, Sexton K, Pirie R, Hudson M, Aspin L. Monitoring sexually transmitted infections among Maori in the Bay of Plenty: a feasibility study. In: New Zealand Sexual Health Society 31st Annual Conference; 2009 October 15–17; Waitangi, New Zealand.
[19] Rose S, Bromhead C, Lawton BA, Baker M, Zhang J, Stanley J. An audit of chlamydia testing in the Wellington region: are those most at risk getting tested? In: New Zealand Sexual Health Society 32nd Annual Conference; 2010 September 9–11; Wellington, New Zealand.
[20] Morgan J, Bell A. The highs and lows of opportunistic chlamydia testing: uptake and detection in Waikato, New Zealand. Sex Transm Infect 2009; 85 452–4.
| The highs and lows of opportunistic chlamydia testing: uptake and detection in Waikato, New Zealand.Crossref | GoogleScholarGoogle Scholar |
[21] STI Surveillance Team. Laboratory surveillance of chlamydia and gonorrhoea in New Zealand. Wellington: Population and Environmental Health Group, Institute of Environmental Science and Research Ltd; 2010. Available online at: http://www.surv.esr.cri.nz/surveillance/quarterly_stilab.php [verified February 2011].
